Long-term follow-up on a diet intervention during pregnancy for cardiovascular health
Cardiovascular Risk Reduction-Diet in Pregnancy - Follow up 20 Years After the "CARRDIP"-Trial
This study looks at how following a Mediterranean diet during pregnancy affects heart health for mothers and their children 20 years later.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 538 (estimated) |
| Sex | All |
| Sponsor | University of Oslo Academic / other |
| Locations | 1 site (Oslo) |
| Trial ID | NCT05030922 on ClinicalTrials.gov |
What this trial studies
The CARRDIP20 trial is a follow-up study examining the long-term effects of a Mediterranean diet intervention during pregnancy on cardiovascular health. Originally conducted 20 years ago, this randomized controlled trial involved 269 healthy pregnant women who were assigned to either an intervention diet or a control group. The current study aims to assess the cardiovascular outcomes for both mothers and their offspring two decades after the initial dietary intervention. Participants will be evaluated to compare health metrics between the two groups.
Who should consider this trial
Good fit: Ideal candidates for this study are women who participated in the original CARRDIP trial and are now 20 years post-intervention.
Not a fit: Patients who did not participate in the original CARRDIP trial or those with significant pregnancy complications may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights into how dietary interventions during pregnancy can influence long-term cardiovascular health for both mothers and children.
How similar studies have performed: Other studies have shown promising results regarding dietary interventions during pregnancy, but this long-term follow-up is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria from original CARRDIP-trial: * Non-smoking pregnant women * BMI 19 to 32 kg/m2 at inclusion * Age 21 to 38 years * Carrying a single foetus Exclusion Criteria: * Previous pregnancy complications
Where this trial is running
Oslo
- University of Oslo — Oslo, Norway (Recruiting)
Study contacts
- Study coordinator: Per Ole Iversen, MD
- Email: p.o.iversen@medisin.uio.no
- Phone: +47 22851391
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.